NEK2 and breast carcinoma: Namely siRNA-mediated knockdown of Nek2 in MCF7, MDA-MB-231 and Hs578T mammary carcinoma cell lines suppressed their proliferation, invasiveness, and anchorage-independent growth in vitro [75].